182 related articles for article (PubMed ID: 8393425)
1. Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations.
Schneider S; Wildhardt G; Ludwig R; Royer-Pokora B
Hum Genet; 1993 Jul; 91(6):599-604. PubMed ID: 8393425
[TBL] [Abstract][Full Text] [Related]
2. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
[TBL] [Abstract][Full Text] [Related]
3. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
Nordenskjöld A; Friedman E; Anvret M
Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of two female patients with incomplete Denys-Drash syndrome.
Ohta S; Ozawa T; Shiraga H; Fuse H
Endocr J; 2000 Dec; 47(6):683-7. PubMed ID: 11228042
[TBL] [Abstract][Full Text] [Related]
5. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
[TBL] [Abstract][Full Text] [Related]
6. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
7. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
[TBL] [Abstract][Full Text] [Related]
8. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B
Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587
[TBL] [Abstract][Full Text] [Related]
9. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
[TBL] [Abstract][Full Text] [Related]
10. Genotype/phenotype correlations in Wilms' tumor.
Huff V
Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
[TBL] [Abstract][Full Text] [Related]
11. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.
Haber DA; Buckler AJ; Glaser T; Call KM; Pelletier J; Sohn RL; Douglass EC; Housman DE
Cell; 1990 Jun; 61(7):1257-69. PubMed ID: 2163761
[TBL] [Abstract][Full Text] [Related]
12. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.
da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S
Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934
[TBL] [Abstract][Full Text] [Related]
13. Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
Barbaux S; Niaudet P; Gubler MC; Grünfeld JP; Jaubert F; Kuttenn F; Fékété CN; Souleyreau-Therville N; Thibaud E; Fellous M; McElreavey K
Nat Genet; 1997 Dec; 17(4):467-70. PubMed ID: 9398852
[TBL] [Abstract][Full Text] [Related]
14. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor].
Jiang YP; Shen Y; Sun N; Wang H
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811
[TBL] [Abstract][Full Text] [Related]
15. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
[TBL] [Abstract][Full Text] [Related]
16. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
[TBL] [Abstract][Full Text] [Related]
17. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion.
Little MH; Williamson KA; Mannens M; Kelsey A; Gosden C; Hastie ND; van Heyningen V
Hum Mol Genet; 1993 Mar; 2(3):259-64. PubMed ID: 8388765
[TBL] [Abstract][Full Text] [Related]
18. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.
Patek CE; Little MH; Fleming S; Miles C; Charlieu JP; Clarke AR; Miyagawa K; Christie S; Doig J; Harrison DJ; Porteous DJ; Brookes AJ; Hooper ML; Hastie ND
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2931-6. PubMed ID: 10077614
[TBL] [Abstract][Full Text] [Related]
19. WT1 Haploinsufficiency Supports Milder Renal Manifestation in Two Patients with Denys-Drash Syndrome.
Guaragna MS; Ribeiro de Andrade JG; de Freitas Carli B; Belangero VM; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
Sex Dev; 2017; 11(1):34-39. PubMed ID: 28081536
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
